Bioventus Inc. (BVS) Reports In-Line Q2 EPS ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mailGet Alerts BVS Hot Sheet
Join SI Premium – FREE
Bioventus Inc. (NASDAQ: BVS) reported Q2 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $147.7 million versus the consensus estimate of $146.28 million.
GUIDANCE:
Bioventus Inc. sees FY2025 EPS of $0.64-$0.68, versus the consensus of $0.66. Bioventus Inc. sees FY2025 revenue of $560-570 million, versus the consensus of $565.4 million.
For earnings history and earnings-related data on Bioventus Inc. (BVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US Treasury: 'Authorizing Wind Down Activities...the Offloading of Cargo Involving Certain Persons or Vessels Blocked on October 21, 2026'
- Elevance Health Inc. (ELV) Tops Q3 EPS by $2.29, Beats on Revenue; Offers FY EPS Guidance
- Winnebago Industries (WGO) Misses Q4 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
